DXZ.TO
Dynamic Active U.S. Mid-Cap ETF
TorontoCADEQUITY
DELAYED
Last price
14.45
▲ 0.32 (2.26%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
14.13
Day high
14.45
Day low
14.45
Volume
76
Market cap
—
P/E (TTM)
—
52W range
12.29 – 14.48
Trailing performance
Returnvs SPY
1W
-2.01%
-0.6%
1M
+0.36%
-3.4%
3M
+7.70%
+4.6%
6M
+4.43%
-6.6%
YTD
+10.74%
-1.6%
1Y
+8.03%
-12.0%
3Y
+28.57%
-45.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on DXZ.TO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.30
+1.07% from price
SMA 20
14.29
-1.12% from price
SMA 50
14.10
+0.18% from price
SMA 100
13.62
+6.12% from price
SMA 200
13.30
+6.25% from price
EMA 12
14.26
+1.30% from price
EMA 26
14.22
+1.60% from price
EMA 50
14.05
+2.82% from price
RSI (14)
46.1
Neutral
MACD (12,26,9)
0.04
Hist -0.04
ATR (14)
0.08
0.55% of price
Realised vol 30D
14.5%
Annualised
Bollinger upper
14.57
20, 2σ
Bollinger lower
14.01
20, 2σ
50 / 200 cross
Golden
14.10 vs 13.30
Trend bias
Above 200
+6.25%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.25
Less volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
14.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-8.8%
Peak to trough
Max drawdown 5Y
-24.2%
Peak to trough
ATR 14
0.08
0.55% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
PR Newswire · 7m ago
India police used excessive force during protests: Amnesty
AFP · 10m ago
California expected to seek TV channel sales from Paramount-Warner, WSJ reports
Reuters · 15m ago
Here's the Smartest S&P 500 Dividend Stock to Buy With $1,000 Right Now -- and It's Sporting a 6.8% Dividend Yield
Motley Fool · 17m ago
Walmart's top-rated mini dresser is just $26 during a Flash deal
TheStreet · 22m ago
Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?
Insider Monkey · 23m ago
The “No-Contest Clause”: One Sentence That Makes Challenging Your Will Cost a Child Everything You Left Them.
24/7 Wall St. · 24m ago
Ukraine backers gather as war escalates, air defence runs low
AFP · 25m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.